Wordt geladen...
Sera from Diabetics does not Alter the Effect of mTOR Inhibition on Smooth Muscle Cell Proliferation
Clinical studies of drug eluting stents delivering the mammalian Target of Rapamycin (mTOR) inhibitor, rapamycin (Sirolimus), have demonstrated a reduced efficacy for these devices in diabetic patients, which suggests the mTOR pathway may cease to be dominant in mediating the vascular response to in...
Bewaard in:
| Hoofdauteurs: | , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
2009
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2891793/ https://ncbi.nlm.nih.gov/pubmed/19129735 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/FJC.0b013e318195b588 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|